New acute myeloid leukemia treatment drugs is the focus of new clinical trials, applied to patients at three sites across the United States. DMNT inhibitor, and decitabine, both drugs have approved by the FDA to treat acute myeloid leukemia and often used as off-label chemotherapy for patients with blood cancers. Besides being use as a new acute myeloid leukemia treatment drugs, the combination has the potential to treat other cancers including breast and ovarian cancer. Where both of this cancer, including diseases that are difficult to treat.

Source: New Acute Myeloid Leukemia Treatment Drugs Promising

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s